Asplenia clinical trials

Explore recruiting asplenia clinical trials.

Recruiting asplenia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Asplenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(BIPAS) A prospective trial to assess Pneumococcal vaccine B cell response in patients without a spleen: a controlled study.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

SPLEMENGO - Multicenter, randomized, phase III, trial assessing the immunogenicity and safety of three meningococal B vaccine strategies among patients with asplenia

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Immunogenicity and safety of a meningococcal serogroup B vaccine in adult patients with asplenia

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Asplenia trials by city

Asplenia in Toronto Asplenia in Vancouver Asplenia in Montreal Asplenia in Calgary Asplenia in Edmonton Asplenia in Ottawa Asplenia in Winnipeg Asplenia in Quebec City Asplenia in Hamilton Asplenia in Kitchener Asplenia in London Asplenia in Halifax Asplenia in New York Asplenia in Los Angeles Asplenia in Chicago Asplenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease